Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|February 22, 2019
Molecular Players in Hematologic Tumor Cell TraffickingJavier Redondo-Muñoz, Angeles García-Pardo, Joaquin Teixidó
The Journal of Biological Chemistry|April 6, 2016
Inhibition of MMP-9-dependent Degradation of Gelatin, but Not Other MMP-9 Substrates, by the MMP-9 Hemopexin Domain Blades 1 and 4Estefanía Ugarte-Berzal, Jennifer Vandooren, Elvira Bailón, et al.
Blood|September 25, 2007
Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migrationJavier Redondo-Muñoz, María José Terol, José A García-Marco, et al.
Oncotarget|November 10, 2016
Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9Irene Amigo-Jiménez, Elvira Bailón, Noemí Aguilera-Montilla, et al.
Blood|July 15, 2006
MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migrationJavier Redondo-Muñoz, Elizabeth Escobar-Díaz, Rafael Samaniego, et al.
Oncotarget|November 6, 2015
Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathwaysIrene Amigo-Jiménez, Elvira Bailón, Noemí Aguilera-Montilla, et al.
The Journal of Biological Chemistry|April 18, 2014
A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cellsEstefanía Ugarte-Berzal, Elvira Bailón, Irene Amigo-Jiménez, et al.
Plos One|June 24, 2014
Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxideIrene Amigo-Jiménez, Elvira Bailón, Estefanía Ugarte-Berzal, et al.
Biochemical and Biophysical Research Communications|April 15, 2015
Arsenic trioxide synergistically potentiates the cytotoxic effect of fludarabine in chronic lymphocytic leukemia cells by further inactivating the Akt and ERK signaling pathwaysCarol Lozano-Santos, Irene Amigo-Jiménez, Sara Nova-Gurumeta, et al.
Journal of Leukocyte Biology|August 1, 2014
Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleenElvira Bailón, Estefanía Ugarte-Berzal, Irene Amigo-Jiménez, et al.
Pageof 3